IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v47y2024i12d10.1007_s40264-024-01468-8.html
   My bibliography  Save this article

Description and Validation of a Novel AI Tool, LabelComp, for the Identification of Adverse Event Changes in FDA Labeling

Author

Listed:
  • George A. Neyarapally

    (FDA)

  • Leihong Wu

    (US Food and Drug Administration (FDA))

  • Joshua Xu

    (US Food and Drug Administration (FDA))

  • Esther H. Zhou

    (FDA)

  • Oanh Dang

    (FDA)

  • Joann Lee

    (FDA)

  • Dharmang Mehta

    (FDA)

  • Rochelle D. Vaughn

    (FDA)

  • Ellen Pinnow

    (FDA)

  • Hong Fang

    (FDA)

Abstract

Introduction The accurate identification and timely updating of adverse reactions in drug labeling are crucial for patient safety and effective drug use. Postmarketing surveillance plays a pivotal role in identifying previously undetected adverse events (AEs) that emerge when a drug is used in broader and more diverse patient populations. However, traditional methods of updating drug labeling with new AE information have been manual, time consuming, and error prone. This paper introduces the LabelComp tool, an innovative artificial intelligence (AI) tool designed to enhance the efficiency and accuracy of postmarketing drug safety surveillance. Utilizing a combination of text analytics and a trained Bidirectional Encoder Representations from Transformers (BERT) model, the LabelComp tool automatically identifies changes in AE terms from updated drug labeling documents. Objective Our objective was to create and validate an AI tool with high accuracy that could enable researchers and FDA reviewers to efficiently identify safety-related drug labeling changes. Results Our validation study of 87 drug labeling PDF pairs demonstrates the tool's high accuracy, with F1 scores of overall performance ranging from 0.795 to 0.936 across different evaluation tiers and a recall of at least 0.997 with only one missed AE out of 483 total AEs detected, indicating the tool's efficacy in identifying new AEs. Conclusion The LabelComp tool can support drug safety surveillance and inform regulatory decision-making. The publication of this tool also aims to encourage further community-driven enhancements, aligning with broader interests in applying AI to advance regulatory science and public health.

Suggested Citation

  • George A. Neyarapally & Leihong Wu & Joshua Xu & Esther H. Zhou & Oanh Dang & Joann Lee & Dharmang Mehta & Rochelle D. Vaughn & Ellen Pinnow & Hong Fang, 2024. "Description and Validation of a Novel AI Tool, LabelComp, for the Identification of Adverse Event Changes in FDA Labeling," Drug Safety, Springer, vol. 47(12), pages 1265-1274, December.
  • Handle: RePEc:spr:drugsa:v:47:y:2024:i:12:d:10.1007_s40264-024-01468-8
    DOI: 10.1007/s40264-024-01468-8
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-024-01468-8
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-024-01468-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Samuel Bayer & Cheryl Clark & Oanh Dang & John Aberdeen & Sonja Brajovic & Kimberley Swank & Lynette Hirschman & Robert Ball, 2021. "ADE Eval: An Evaluation of Text Processing Systems for Adverse Event Extraction from Drug Labels for Pharmacovigilance," Drug Safety, Springer, vol. 44(1), pages 83-94, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      More about this item

      Statistics

      Access and download statistics

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:47:y:2024:i:12:d:10.1007_s40264-024-01468-8. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.